Cargando…

STK1p as a prognostic biomarker for overall survival in non-small-cell lung carcinoma, based on real-world data

AIM: A prospective investigation of serum thymidine kinase 1 concentration (STK1p) was performed to evaluate its prognostic value in patients with non-small-cell lung carcinoma (NSCLCs). PATIENTS & METHODS: The STK1p values of 127 patients were determined by an enhanced chemiluminescent dot blot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhenxin, Zhang, Guoqing, Li, Zhongcheng, Li, Jin, Ma, Hongbo, Hei, Ailian, Jiao, Shunchang, Hu, Yi, Sun, Shengjie, Wu, Liangliang, Zhou, Ji, Wang, Yu, He, Ellen, Skog, Sven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Science Ltd 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849927/ https://www.ncbi.nlm.nih.gov/pubmed/33552542 http://dx.doi.org/10.2144/fsoa-2020-0130

Ejemplares similares

Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis
por: Ma, Hongbo, et al.
Publicado: (2021)

A meta-analysis of serological thymidine kinase 1 as a marker for colorectal benign and malignant tumor risk assessment
por: Dang, Li, et al.
Publicado: (2020)

STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world
por: Shire, Norah J., et al.
Publicado: (2020)

Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
por: Fang, Yujing, et al.
Publicado: (2023)

STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
por: Papillon-Cavanagh, Simon, et al.
Publicado: (2020)

Correction: STK11 and KEAP1 mutations as prognostic biomarkers in an observational real-world lung adenocarcinoma cohort
Publicado: (2020)

Real-world treatment efficacy of anti-programmed death-1 combined with anti-angiogenesis therapy in non-small cell lung cancer patients
por: Qiu, Lupeng, et al.
Publicado: (2020)

Diversity of Dominant Peripheral T Cell Receptor Clone and Soluble Immune Checkpoint Proteins Associated With Clinical Outcomes Following Immune Checkpoint Inhibitor Treatment in Advanced Cancers
por: Li, Ye, et al.
Publicado: (2021)

Novel neutralizing chicken IgY antibodies targeting 17 potent conserved peptides identified by SARS-CoV-2 proteome microarray, and future prospects
por: Li, Jin, et al.
Publicado: (2022)

Development of a Novel Recombinant Full-Length IgY Monoclonal Antibody against Human Thymidine Kinase 1 for Automatic Chemiluminescence Analysis on a Sandwich Biotin-Streptavidin Platform for Early Tumour Discovery
por: Wang, Xiangbin, et al.
Publicado: (2023)

Overall survival in patients with advanced non-small cell lung cancer with KRAS G12C mutation with or without STK11 and/or KEAP1 mutations in a real-world setting
por: Julian, Cristina, et al.
Publicado: (2023)

Prognostic and Immunological Role of STK38 across Cancers: Friend or Foe?
por: Liu, Yankuo, et al.
Publicado: (2022)

High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia
por: Yu, Xibao, et al.
Publicado: (2023)

STK system acceptance tests
por: Grau, X F
Publicado: (1997)

Prognostic and immune-related value of STK17B in skin cutaneous melanoma
por: Shi, Xueying, et al.
Publicado: (2022)

Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation
por: Nie, Wei, et al.
Publicado: (2021)

Serine/Threonine Protein Kinase STK16
por: Wang, Junjun, et al.
Publicado: (2019)

High STK40 Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Low-Grade Gliomas
por: Pan, Heyue, et al.
Publicado: (2021)

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis
por: Wu, Zhentian, et al.
Publicado: (2023)

Construction of an STK11 Mutation and Immune-Related Prognostic Prediction Model in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2023)

STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma
por: Bai, Zi-Yuan, et al.
Publicado: (2023)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
por: Li, Yadong, et al.
Publicado: (2023)

Nuclear TK1 expression is an independent prognostic factor for survival in pre-malignant and malignant lesions of the cervix
por: Chen, Gang, et al.
Publicado: (2013)

STK17B promotes the progression of ovarian cancer
por: Jiang, Liping, et al.
Publicado: (2021)

ZmSTK1 and ZmSTK2, encoding receptor‐like cytoplasmic kinase, are involved in maize pollen development with additive effect
por: Fan, Mingxia, et al.
Publicado: (2018)

The Clinical Application Value of the Prognostic Nutritional Index for the Overall Survival Prognosis of Patients with Esophageal Cancer: A Robust Real-World Observational Study in China
por: Kang, Juanjuan, et al.
Publicado: (2022)

Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data: PRO.M.E.THE.O.
por: Miccichè, Francesco, et al.
Publicado: (2022)

stk: A python toolkit for supramolecular assembly
por: Turcani, Lukas, et al.
Publicado: (2018)

STK16 regulates actin dynamics to control Golgi organization and cell cycle
por: Liu, Juanjuan, et al.
Publicado: (2017)

Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases
por: Yu, Xiaoqing, et al.
Publicado: (2019)

Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real‐world study
por: Hang, Junjie, et al.
Publicado: (2018)

Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer
por: Pécuchet, Nicolas, et al.
Publicado: (2015)

Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia
por: Bi, Lei, et al.
Publicado: (2022)

A nomogram-based immunoprofile predicts overall survival for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy
por: Duan, Jingjing, et al.
Publicado: (2018)

STK33 overexpression in hypopharyngeal squamous cell carcinoma: possible role in tumorigenesis
por: Huang, Lingyan, et al.
Publicado: (2015)

Knockout of STK10 promotes the migration and invasion of cervical cancer cells
por: Zhang, Lu, et al.
Publicado: (2020)

Efficacy and Safety of Anlotinib in Overall and Disease-Specific Advanced Gynecological Cancer: A Real-World Study
por: Hong, Xinyi, et al.
Publicado: (2023)

STK25 inhibits PKA signaling by phosphorylating PRKAR1A
por: Zhang, Xiaokan, et al.
Publicado: (2022)

Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

Dynamic Prediction of Near-Term Overall Survival in Patients with Advanced NSCLC Based on Real-World Data
por: Wang, Xuechen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ii9b6ihr4t9ecrpmno1car9g3p